"10.1371_journal.pone.0028062","plos one","2011-11-30T00:00:00Z","Kresimir Dolic; Bianca Weinstock-Guttman; Karen Marr; Vesela Valnarov; Ellen Carl; Jesper Hagemeier; Christina Brooks; Colleen Kilanowski; David Hojnacki; Murali Ramanathan; Robert Zivadinov","Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, New York, United States of America; Department of Neurology, The Jacobs Neurological Institute, Kaleida Health, University at Buffalo, State University of New York, Buffalo, New York, United States of America; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, United States of America","Conceived and designed the experiments: KD BW-G KM RZ. Performed the experiments: KD BW-G KM VV EC JH CB CK DH MR RZ. Analyzed the data: KD BW-G EC JH RZ. Contributed reagents/materials/analysis tools: KM VV EC JH CB CK. Wrote the paper: KD RZ.","DH has received speaker honoraria and consultant fees from Biogen Idec, Teva Pharmaceutical Industries Ltd., EMD Serono, Pfizer Inc, and Novartis. BW-G received personal compensation for consulting, speaking and serving on a scientific advisory board for Biogen Idec, Teva Neuroscience and EMD Serono. BW-G also received financial support for research activities from the National Multiple Sclerosis Society (NMSS), National Institutes of Health, Immune Tolerance Network, Teva Neuroscience, Biogen Idec, EMD Serono, and Aspreva. MR served as an editor for the American Association of Pharmaceutical Scientists Journal, receives royalties for publishing The Pharmacy Calculations Workbook [Pinnacle, Summit and Zenith, 2008], and received research support from EMD Serono, Novartis, Pfizer, NMSS, and the National Science Foundation. RZ received personal compensation from Teva Neuroscience, Biogen Idec, EMD Serono and Questcor Pharmaceuticals for speaking and consultant fees. RZ also received financial support for research activities from Biogen Idec, Teva Neuroscience, Genzyme, Bracco, Questcor Pharmaceuticals and EMD Serono. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","11","Kresimir Dolic","KD",11,TRUE,4,11,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
